All News

2019

October

Media Release / Oct 15, 2019

Sandoz and Pear Therapeutics announce Pear will solely commercialize reSET® and reSET-O®

Read More

September

Media Release / Sep 23, 2019

Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product

Read More
Media Release / Sep 05, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More

August

Media Release / Aug 29, 2019

Sandoz Inc. voluntarily recalls Losartan Potassium and Ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements

Read More
Media Release / Aug 08, 2019

IMPORTANT UPDATE: Formulary wins for SYMJEPI®

Read More

July

Media Release / Jul 09, 2019

Sandoz extends SYMJEPI™ (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine

Read More
Media Release / Jul 01, 2019

SANDOZ makes SYMJEPI™ (epinephrine) 0.3 mg Injection donation to Americares

Read More

June

Media Release / Jun 27, 2019

Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals

Read More
Media Release / Jun 04, 2019

Novartis and Sandoz Honored with Power of Partnership Award

Read More

May

Media Release / May 29, 2019

Sandoz launches Fulvestrant Injection, the first generic version of FASLODEX®, in the US

Read More